Ketamine Addiction
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Episodes of long duration of withdrawal symptoms (depression, anxiety, mania, tinnitus, nausea, unexplained fear, and dizziness) were described after SNRIs discontinuation, suggesting the occurrence of persistent post-withdrawal disorders.
“Episodes of long duration of withdrawal symptoms (i.e., depression, anxiety, mania, tinnitus, nausea, unexplained fear, and dizziness) were described after SNRIs discontinuation, suggesting the occurrence of persistent post-withdrawal disorders [120-123].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [120]
The Ketamine Addiction case report (pp. 1–2) concerns ketamine dependence, not SNRI discontinuation. Its withdrawal discussion (p. 2) says this patient had no physical withdrawal syndrome. Searches for SNRI discontinuation and the listed persistent symptoms found no passage addressing the claim. (LLM, conf=0.78)
Experimental — accuracy not yet measured3 out of the 4 studies reporting SNRI persistent post-withdrawal disorders were on venlafaxine and 1 was on duloxetine.
“To be noted that 3 out of the 4 studies reporting SNRI persistent post-withdrawal disorders were on venlafaxine [120-122] and 1 was on duloxetine [123].”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [120]
The citation [123] is attached to the claim about one duloxetine study. Our copy of “Ketamine Addiction” (pp. 1–2) reports a ketamine-dependence case, not a duloxetine study. Searches for duloxetine, venlafaxine, and persistent SNRI post-withdrawal disorders found no relevant passage. (LLM, conf=0.79)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Journey through the K-hole: Phenomenological aspects of ketamine use
Muetzelfeldt, L., Kamboj, S. K., Rees, H., Taylor, J., Morgan, C. J. A., & Curran, H. V. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.01.024 · Cited by 246 · see citing works
A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences
Jansen, K. L. R. (2000) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2000.10400244 · Cited by 229 · see citing works
Wolff, K., & WINSTOCK, A. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00003 · Cited by 209 · see citing works
The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence
Jansen, K. L. R., & Darracot-Cankovic, R. (2001) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2001.10400480 · Cited by 137 · see citing works
Illicit Use of Ketamine in Scotland
Dalgarno, P., & Shewan, D. (1996) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1996.10524391 · Cited by 133 · see citing works
Recent Trends in the Use of “Club Drugs”: An Australian Review
Degenhardt, L. J., Copeland, J., & Dillon, P. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066777 · Cited by 114 · see citing works
Suzuki, T., Kato, H., Tsuda, M., Suzuki, H., & Misawa, M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00036-3 · Cited by 116 · see citing works
Morgan, C. J. A., Mofeez, A., Brandner, B., Bromley, L. M., & Curran, H. V. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1656-y · Cited by 106 · see citing works
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89 · see citing works
Pal, H. R., Berry, N., Kumar, R., & Ray, R. (2002) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0203000323 · Cited by 87 · see citing works
Attentional bias to incentive stimuli in frequent ketamine users
Morgan, C. J. A., Rees, H., & Curran, H. V. (2008) · Psychological Medicine · doi:10.1017/s0033291707002450 · Cited by 76 · see citing works
Ketamine Dependence in Anesthesia Providers
Moore, N. N., & Bostwick, J. M. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71231-4 · Cited by 70 · see citing works
The clinical toxicology of ketamine
Schep, L. J., Slaughter, R. J., Watts, M., Mackenzie, E., & Gee, P. (2023) · Clinical Toxicology · doi:10.1080/15563650.2023.2212125 · Cited by 74 · see citing works
The health and psycho-social consequences of ketamine use
Copeland, J., & Dillon, P. (2005) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2004.12.003 · Cited by 55 · see citing works
Kolp, E., Friedman, H. L., Krupitsky, E. M., Jansen, K., Sylvester, M., Young, M. S., & Kolp, A. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.2.84 · Cited by 58 · see citing works
Dotson, J. W., Ackerman, D. L., & West, L. J. (1995) · Journal of Drug Issues · doi:10.1177/002204269502500407 · Cited by 47 · see citing works
Swainson, J., Klassen, L. J., Brennan, S., Chokka, P. R., Katzman, M. A., Tanguay, R. L., & Khullar, A. (2022) · CNS Drugs · doi:10.1007/s40263-022-00897-2 · Cited by 47 · see citing works
Babar, E., Özgünen, T., Melik, E., Polat, S., & Akman, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01340-1 · Cited by 38 · see citing works
Simpson, D., Braithwaite, R. A., Jarvie, D. R., et al. (1997) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329703400502 · Cited by 38 · see citing works
Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists
Zarantonello, P., Bettini, E., Paio, A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.02.009 · Cited by 37 · see citing works
Suzuki, T., Aoki, T., KATO, H. E., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00762-1 · Cited by 35 · see citing works
Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine
Cardona-Acosta, A. M., & Bolaños‐Guzmán, C. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109374 · Cited by 36 · see citing works
Buck, M. L., & Blumer, J. L. (1991) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30298-7 · Cited by 28 · see citing works
Craving and addictive potential of esketamine as side effects?
Orsolini, L., Salvi, V., & Volpe, U. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2071422 · Cited by 16 · see citing works
Drug use in South Wales: who uses Ecstasy anyway?
Handy, C., Pates, R. M., & Barrowcliff, A. L. (1998) · Journal of Substance Misuse · doi:10.3109/14659899809053478 · Cited by 14 · see citing works
Toyama, Y., Shimizu, H., Suzuki, Y., Miyakoshi, Y., & Yoshioka, H. (2006) · Environmental Health and Preventive Medicine · doi:10.1265/ehpm.11.120 · Cited by 14 · see citing works
Arditti, J., Spadari, M., de Haro, L., Brun, A., Jh, B., & Valli, M. (2002) · Acta Clinica Belgica · doi:10.1179/acb.2002.073 · Cited by 12 · see citing works
Zhang, S., Ye, B., Zeng, L., et al. (2012) · PubMed · Cited by 10 · see citing works
Non-narcotic Modalities for the Management of Acute Pain
Lee, V. C. (1990) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30384-1 · Cited by 10 · see citing works
Ketamine Abuse: Past and Present
Huang, M., & Lin, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2902-3_1 · Cited by 8 · see citing works
Bayer, E. W., & Woolf, A. D. (2000) · Clinical Pediatric Emergency Medicine · doi:10.1016/s1522-8401(00)90025-9 · Cited by 6 · see citing works
Incrocci, R. M., Paliarin, F., & Nobre, M. J. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.08.013 · Cited by 5 · see citing works
Exposure to Common Anesthetic Agents Alters Pup-retrieval Response in Lactating Rtas
Yamamuro, Y. (2005) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.54.369 · Cited by 5 · see citing works
Ketamine: Its Safety, Tolerability, and Impact on Neurocognition
Rybakowski, J., Permoda-Osip, A., & Bartkowska-Śniatkowska, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0_5 · Cited by 3 · see citing works
Non-narcotic Modalities for the Management of Acute Pain
Lee, V. C. (1989) · Anesthesiology Clinics of North America · doi:10.1016/s0889-8537(21)00225-x · Cited by 4 · see citing works
Wolff, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_15 · Cited by 3 · see citing works
Ketamine in Psychiatric Disorders
Danyeli, L. V., Götting, F. N., Şen, Z. D., Li, M., & Walter, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_420 · Cited by 1 · see citing works
Ketamine in Chronic Pain: A Review
Davis, S. (1998) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr199828294 · Cited by 1 · see citing works
Weaver, M. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-32132-5_78-2 · Cited by 1 · see citing works
Ketamin in der Therapie chronischer Schmerzen
Gehling, M., & Tryba, M. (2002) · Springer eBooks · doi:10.1007/978-3-662-09790-8_5
Ketamine in Psychiatric Disorders
Danyeli, L. V., Götting, F. N., Şen, Z. D., Li, M., & Walter, M. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_420-1
Bonson, K. R., & Baggott, M. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-165-7_9
Barceloux, D. G. (2012) · Wiley eBooks · doi:10.1002/9781118105955.ch7
Weaver, M. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-33228-4_78
General anesthetics and therapeutic gases
Malinge, M., & Larousse, C. (1989) · Side effects of drugs annual · doi:10.1016/s0378-6080(89)80016-9
Fu, Y., Zou, J., Zhao, W., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3319415/v1
Weaver, M. F., & Schnoll, S. H. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_28
- Authors
- KAMAYA, H., & KRISHNA, P. R.
- Affiliations
- University of Utah (US)
- Venue
- Anesthesiology
- Published
- 1987-11-01
- Volume
- 67
- Issue
- 5
- Pages
- 861-862
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W4247737563
- Cited by
- 48
- References
- 0
- Citations by year
- 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2016: 2 · 2014: 1 · 2012: 3
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Anesthesiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- ketamine, drug addiction, substance use disorders, dissociative drugs
- MeSH terms
- Adult, Humans, Ketamine, Male, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
